Generally I don't give too much credit to analysts coverage coz most of them just do sloppy job. That said, a couple of them that cover mnkd are:-

• Matthew Lowe : JPMorgan
• Tazeen Ahmad : Bank of America Merrill Lynch
• Seamus Fernandez : Leerink Swann
• Thomas Russo : Robert W. Baird
• Keith Markey : Griffin Securities

We all know by now Keith Markey of Griffin Securities and his preposterous bullish sentiment since way back in 2010...and in fact still maintains $14 target price. I don't mean to discount his research...but he just seems overtly bullish for my taste.

One particular name to note is Tom Russo. This guy takes the #3 top biotech stock picker for 2012 as ranked by Starmine/WSJ. This is top honors for analysts.

http://excellence.thomsonreuters.com/awards/starmine/analyst-awards/2012/united-states

I particularly find it impressive that he called out MNKD with a "Sell" rating back in Jan 2011 (we were trading at $6) with a price target of $2. He was right on his call 1.5 years and rolling.